Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Miyano

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Pharmaceutics|November 9, 2023
Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third ComponentHiroshi Ueda, Yuya Hirakawa, Tetsuya Miyano, et al.
Nature Communications|May 9, 2013
Linkage control between molecular and supramolecular chirality in 2₁-helical hydrogen-bonded networks using achiral componentsToshiyuki Sasaki, Ichiro Hisaki, Tetsuya Miyano, et al.
Molecular Pharmaceutics|March 22, 2022
Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition TemperatureHiroshi Ueda, Yuya Hirakawa, Tetsuya Miyano, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 23, 2018
Dynamic Polymorph Formation during Evaporative Crystallization from Solution: The Key Role of Liquid-Like Clusters as "Crucible" at Ambient TemperatureNarumi Oka, Fuyuki Ito, Yohei Haketa, et al.
Chemical & Biomedical Imaging|February 27, 2026
Live-Cell Raman Imaging Elucidates Intracellular Distribution of Macrocyclic Peptides Designed as HIV Protease InhibitorsYasunori Nawa, Tetsuya Miyano, Kazuki Bando, et al.
Journal of Medicinal Chemistry|July 5, 2025
Discovery of the Clinical Candidate <b>S-892216</b>: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19Yuto Unoh, Keiichiro Hirai, Shota Uehara, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Pharmaceutics|November 9, 2023
Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third ComponentHiroshi Ueda, Yuya Hirakawa, Tetsuya Miyano, et al.
Nature Communications|May 9, 2013
Linkage control between molecular and supramolecular chirality in 2₁-helical hydrogen-bonded networks using achiral componentsToshiyuki Sasaki, Ichiro Hisaki, Tetsuya Miyano, et al.
Molecular Pharmaceutics|March 22, 2022
Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition TemperatureHiroshi Ueda, Yuya Hirakawa, Tetsuya Miyano, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 23, 2018
Dynamic Polymorph Formation during Evaporative Crystallization from Solution: The Key Role of Liquid-Like Clusters as "Crucible" at Ambient TemperatureNarumi Oka, Fuyuki Ito, Yohei Haketa, et al.
Chemical & Biomedical Imaging|February 27, 2026
Live-Cell Raman Imaging Elucidates Intracellular Distribution of Macrocyclic Peptides Designed as HIV Protease InhibitorsYasunori Nawa, Tetsuya Miyano, Kazuki Bando, et al.
Journal of Medicinal Chemistry|July 5, 2025
Discovery of the Clinical Candidate <b>S-892216</b>: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19Yuto Unoh, Keiichiro Hirai, Shota Uehara, et al.
Pageof 2